John Wiley & Sons (WLYB) EBITDA (2009 - 2026)

John Wiley & Sons (WLYB) has reported EBITDA for 18 consecutive years, with $2.9 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, EBITDA fell 90.51% year-over-year to $2.9 million in Q3 2026; TTM through Jul 2026 was $248.8 million, a 11.39% increase from a year earlier, with the FY2026 full-year figure at $276.9 million, up 25.04% from the prior year.
• EBITDA was $2.9 million for Q3 2026 at John Wiley & Sons, down from $110.1 million in the prior quarter.
• Over five years, EBITDA peaked at $110.1 million in Q2 2026 and troughed at -$67.1 million in Q1 2023.
• A 5-year average of $40.6 million and a median of $54.6 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA slumped 245.81% in 2023 and surged 211.68% in 2025, its largest moves.
• Over 5 years, EBITDA stood at $57.4 million in 2022, then retreated by 19.49% to $46.2 million in 2023, then jumped by 38.68% to $64.1 million in 2024, then rose by 13.82% to $73.0 million in 2025, then tumbled by 95.98% to $2.9 million in 2026.
• The last three EBITDA figures came in at $2.9 million (Q3 2026), $110.1 million (Q2 2026), and $62.8 million (Q1 2026), per Business Quant data.